SCHEMBL13699710

SCHEMBL13699710

NC(=O)c1oc2ccc(Cl)cc2c1NC(=O)c1cccc(Cl)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.67
ALDH1A1 P00352 5/20 0.60
HSD17B10 Q99714 5/20 0.57
HPGD P15428 5/20 0.57
MAPK10 P53779 4/20 0.57
MEN1 O00255 4/20 0.57
KMT2A Q03164 4/20 0.57
TSHR P16473 3/20 0.57
NPSR1 Q6W5P4 1/20 0.57
MAPK1 P28482 2/20 0.52
TP53 P04637 3/20 0.52
MAPT P10636 2/20 0.52
AHR P35869 1/20 0.52
KCNMA1 Q12791 1/20 0.47
LMNA P02545 1/20 0.47
ALOX15 P16050 1/20 0.47
PARP1 P09874 1/20 0.47
TEAD1 P28347 1/20 0.46
YAP1 P46937 1/20 0.46
TEAD4 Q15561 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4251178 0.91 ALDH1A1 (0.72) KDM4EALDH1A1HSD17B10HPGDMAPK10
SCHEMBL13699708 0.91 MAPT (0.60) KDM4EALDH1A1HSD17B10HPGDMAPK10
SCHEMBL13699769 0.87 HPGD (0.63) KDM4EALDH1A1HSD17B10HPGDMAPK10
SCHEMBL13699831 0.85 KDM4E (0.61) KDM4EALDH1A1HSD17B10HPGDMAPK10
SCHEMBL13699972 0.84 KDM4E (0.54) KDM4EALDH1A1HSD17B10HPGDMAPK10
SCHEMBL13699692 0.84 TP53 (0.70) KDM4EALDH1A1HSD17B10HPGDMAPK10
SCHEMBL13699724 0.84 KDM4E (0.70) KDM4EALDH1A1HSD17B10HPGDMAPK10
SCHEMBL13699693 0.84 TP53 (0.57) KDM4EALDH1A1HSD17B10HPGDMAPK10
SCHEMBL13699807 0.83 KDM4E (0.65) KDM4EALDH1A1HSD17B10HPGDMAPK10
SCHEMBL13699699 0.83 TP53 (0.65) KDM4EALDH1A1HSD17B10HPGDMAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885ALDH1A1 559/4885HSD17B10 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.